Korean J Obstet Gynecol.  2012 Aug;55(8):590-595. 10.5468/KJOG.2012.55.8.590.

A case of pathologic fracture of the proximal femur resulting from metastatic bone tumor of ovarian immature teratoma

Affiliations
  • 1Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. th2580.kim@samsung.com
  • 2Department of Orthopedics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Abstract

Composing of less than 1% of all ovarian cancers, immature teratoma is a malignancy that mainly affects the young. In this report, we present the first case of pathologic fracture of the proximal femur resulting from metastatic bone tumor of ovarian immature teratoma. A 33-year-old Korean female was diagnosed as immature teratoma of stage Ia and grade 3. Eleven months following initial surgery, she had developed right thigh pain and palpable mass, which was confirmed metastasis of immature teratoma. She had her right leg broken during concurrent chemoradiation. She took mass excision, closed reduction with internal fixation and allo-bone graft followed by 6 cycles of chemotherapy and 10 times of radiotherapy. Now she is on regular follow-up and remained disease-free for 14 months.

Keyword

Bone neoplasm; Teratoma; Fractures; Spontaneous; Ovary

MeSH Terms

Adult
Bone Neoplasms
Female
Femur
Follow-Up Studies
Fractures, Spontaneous
Humans
Leg
Neoplasm Metastasis
Ovarian Neoplasms
Ovary
Teratoma
Thigh
Transplants

Figure

  • Fig. 1 Initial imaging studies. (A) Plain radiography of the thigh. No pathologic fracture. (B) Magnetic resonance imaging finding. 20×5×4 cm sized solid mass in proximal to mid portion of right femur involving soft-tissue mass and vastus intermedius muscle.

  • Fig. 2 The pathologic finding of immature teratoma, incisonal biopsy at right thigh palpable mass. (A) Gandular, stromal and muscular differentiations was noted (H&E, ×40). (B) Multifocal malignant transforming area (H&E, ×100). (C, D) Mesenchymal and epithelial cell shows polymorphic and hyperchromatic change with prominent nucleoli. Malignant transformation was detected (H&E, ×200).

  • Fig. 3 Plain radiography findings. (A) Fracture of right femur mid-shaft. (B) Postoperation findings.


Reference

1. Nogales FF Jr, Favara BE, Major FJ, Silverberg SG. Immature teratoma of the ovary with a neural component ("solid" teratoma). A clinicopathologic study of 20 cases. Hum Pathol. 1976. 7:625–642.
2. Norris HJ, Zirkin HJ, Benson WL. Immature (malignant) teratoma of the ovary: a clinical and pathologic study of 58 cases. Cancer. 1976. 37:2359–2372.
3. Williams S, Blessing JA, Liao SY, Ball H, Hanjani P. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. J Clin Oncol. 1994. 12:701–706.
4. Kurata A, Hirano K, Nagane M, Fujioka Y. Immature teratoma of the ovary with distant metastases: favorable prognosis and insights into chemotherapeutic retroconversion. Int J Gynecol Pathol. 2010. 29:438–444.
5. Long L, Jiang P, Liu FZ, Wang XP, Zhao TJ. Treatment of ovarian malignant germ cell tumors with preservation of fertility. Chin Med J (Engl). 1993. 106:303–306.
6. Kawai M, Kano T, Furuhashi Y, Iwata M, Nakashima N, Imai N, et al. Immature teratoma of the ovary. Gynecol Oncol. 1991. 40:133–137.
7. Gallion H, van Nagell JR Jr, Donaldson ES, Hanson MB, Powell DF. Immature teratoma of the ovary. Am J Obstet Gynecol. 1983. 146:361–365.
8. Munkarah A, Gershenson DM, Levenback C, Silva EG, Messing MJ, Morris M, et al. Salvage surgery for chemorefractory ovarian germ cell tumors. Gynecol Oncol. 1994. 55:217–223.
9. Gadducci A, Cosio S, Muraca S, Genazzani AR. The management of malignant nondysgerminomatous ovarian germ cell tumors. Anticancer Res. 2003. 23:1827–1836.
10. Cushing B, Giller R, Ablin A, Cohen L, Cullen J, Hawkins E, et al. Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group. Am J Obstet Gynecol. 1999. 181:353–358.
11. Petty RD, Gilbert F, Hutcheon AW, Sarkar TK, McNally O, Parkin D. Bone metastasis from epithelial ovarian carcinoma. Lancet Oncol. 2002. 3:513.
12. Dubuc-Lissoir J, Berthiaume MJ, Boubez G, Van Nguyen T, Allaire G. Bone metastasis from a granulosa cell tumor of the ovary. Gynecol Oncol. 2001. 83:400–404.
13. Pasricha R, Tiwari A, Aggarwal T, Lal P. Carcinoma of uterine cervix with isolated metastasis to fibula and its unusual behavior: report of a case and review of literature. J Cancer Res Ther. 2006. 2:79–81.
14. Litton GJ, Ward JH, Abbott TM, Williams HJ Jr. Isolated calcaneal metastasis in a patient with endometrial adenocarcinoma. Cancer. 1991. 67:1979–1983.
15. Gottwald L, Dukowicz A, Piekarski J, Misiewicz B, Spych M, Misiewicz P, et al. Bone metastases from gynaecological epithelial cancers. J Obstet Gynaecol. 2012. 32:81–86.
16. Ogura K, Miyake R, Shiina S, Shinoda Y, Okuma T, Kobayashi H, et al. Bone radiofrequency ablation combined with prophylactic internal fixation for metastatic bone tumor of the femur from hepatocellular carcinoma. Int J Clin Oncol. 2011. 09. 15. [Epub]. DOI: http://dx.doi.org/10.1007/s10147-011-0319-y.
17. Hipp JA, Springfield DS, Hayes WC. Predicting pathologic fracture risk in the management of metastatic bone defects. Clin Orthop Relat Res. 1995. 120–135.
18. Masopust J, Kithier K, Rádl J, Koutecký J, Kotál L. Occurrence of fetoprotein in patients with neoplasms and non-neoplastic diseases. Int J Cancer. 1968. 3:364–373.
19. Esterhay RJ Jr, Shapiro HM, Sutherland JC, McIntire KR, Wiernik PH. Serum alpha fetoprotein concentration and tumor growth dissociation in a patient with ovarian teratocarcinoma. Cancer. 1973. 31:835–839.
20. Lentini JF, Love MB, Ritchie WG, Sedlacek TV. Computed tomography in retroconversion of hepatic metastases from immature ovarian teratoma. J Comput Assist Tomogr. 1986. 10:1060–1062.
21. Caldas C, Sitzmann J, Trimble CL, McGuire WP 3rd. Synchronous mature teratomas of the ovary and liver: a case presenting 11 years following chemotherapy for immature teratoma. Gynecol Oncol. 1992. 47:385–390.
22. Geisler JP, Goulet R, Foster RS, Sutton GP. Growing teratoma syndrome after chemotherapy for germ cell tumors of the ovary. Obstet Gynecol. 1994. 84:719–721.
23. Li H, Hong W, Zhang R, Wu L, Liu L, Zhang W. Retrospective analysis of 67 consecutive cases of pure ovarian immature teratoma. Chin Med J (Engl). 2002. 115:1496–1500.
Full Text Links
  • KJOG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr